ABCC9 encodes SUR2, a metabolic sensor protein that has been shown to change (expression and function) in aging.
ABCC9 is also strongly implicated in vasoregulation.
ABCC9 has been implicated in neurologic diseases including sleep, depression, and hippocampal sclerosis of aging (HS-Aging).
HS-Aging is a prevalent and impactful brain disease of advanced old age.
ABCC9/SUR2 is a potentially druggable target that may provide a future therapeutic strategy.